Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 257
Filter
1.
Bone Joint J ; 101-B(9): 1151-1159, 2019 09.
Article in English | MEDLINE | ID: mdl-31474143

ABSTRACT

AIMS: We analyzed the long-term outcomes of patients observed over ten years after resection en bloc and reconstruction with extracorporeal irradiated autografts. PATIENTS AND METHODS: This retrospective study included 27 patients who underwent resection en bloc and reimplantation of an extracorporeal irradiated autograft. The mean patient age and follow-up period were 31.7 years (9 to 59) and 16.6 years (10.3 to 24.3), respectively. The most common diagnosis was osteosarcoma (n = 10), followed by chondrosarcoma (n = 6). The femur (n = 13) was the most frequently involved site, followed by the tibia (n = 7). There were inlay grafts in five patients, intercalary grafts in 15 patients, and osteoarticular grafts in seven patients. Functional outcome was evaluated with the Musculoskeletal Tumor Society (MSTS) scoring system. RESULTS: There were no recurrences in the irradiated autograft and the autograft survived in 24 patients (88.9%). Major complications included nonunion (n = 9), subchondral bone collapse (n = 4), and deep infection (n = 4). Although 34 revision procedures were performed, 25 (73.5%) and four (11.8%) of these were performed less than five years and ten years after the initial surgery, respectively. The mean MSTS score at the last follow-up was 84.3% (33% to 100%). CONCLUSION: Considering long-term outcomes, extracorporeal irradiated autograft is an effective method of reconstruction for malignant musculoskeletal tumours Cite this article: Bone Joint J 2019;101-B:1151-1159.


Subject(s)
Bone Neoplasms/radiotherapy , Bone Neoplasms/surgery , Bone and Bones/surgery , Limb Salvage/methods , Replantation , Transplantation, Autologous/methods , Adolescent , Adult , Autografts/radiation effects , Bone and Bones/radiation effects , Child , Follow-Up Studies , Graft Survival , Humans , Middle Aged , Radiotherapy/methods , Plastic Surgery Procedures/methods , Recovery of Function , Retrospective Studies , Transplantation, Autologous/adverse effects , Young Adult
2.
Am J Transplant ; 14(5): 1136-41, 2014 May.
Article in English | MEDLINE | ID: mdl-24698537

ABSTRACT

Chronic inflammation may contribute to human immunodeficiency virus (HIV) persistence through a number of potential pathways. We explored the impact of immunosuppressant therapy on peripheral blood measures of HIV persistence following kidney transplantation. Stored plasma and peripheral blood mononuclear cells prior to transplantation and at weeks 12, 26, 52 and 104 posttransplant were obtained from 91 transplant recipients. In a multivariate model, higher pretransplant plasma HIV RNA level (p < 0.0001) and a longer duration of follow-up posttransplant (p = 0.09) were associated with higher posttransplant plasma HIV RNA levels. A higher baseline HIV DNA (p < 0.0001) was significantly associated with higher HIV DNA levels posttransplant, while higher CD4+ T cell count (p = 0.001), sirolimus use (p = 0.04) and a longer duration of follow-up (p = 0.06) were associated with lower posttransplant HIV DNA levels. The association between sirolimus exposure and lower frequency of cells containing HIV DNA levels posttransplant suggest that the immune-modifying drugs may affect the level of HIV persistence during effect therapy. Future studies of sirolimus as a reservoir-modifying agent are warranted.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Graft Survival/drug effects , HIV Infections/prevention & control , Immunosuppressive Agents/therapeutic use , Kidney Failure, Chronic/surgery , Kidney Transplantation , Female , Follow-Up Studies , HIV/genetics , HIV/isolation & purification , HIV/metabolism , HIV Infections/immunology , HIV Infections/virology , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/virology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/virology , Male , Middle Aged , Prognosis , RNA, Viral/blood , Retrospective Studies , Survival Rate , Transplant Recipients
3.
Oral Dis ; 18(8): 756-62, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22642601

ABSTRACT

OBJECTIVES: An odontoma, which shows proliferating odontogenic epithelium and mesenchymal tissue, is one of the most common odontogenic tumors encountered. These are commonly found in tooth-bearing regions, although the etiology remains unknown. There are no previous reports of an established line of immortalized human odontoma cells. METHODS: Using odontoma fragments obtained from a girl treated at our department, we established an immortalized human odontoma cell line and investigated cell morphology, dynamic proliferation, the presence of contamination, and karyotype. Moreover, cell characterization was examined using osteogenic and odontogenic markers. RESULTS: We successfully established a mesenchymal odontoma cell (mOd cells). The cells were found to be fibroblastic and had a high level of telomerase activity. Cell growth was confirmed after more than 200 population doublings without significant growth retardation. mOd cells expressed mRNA for differentiation markers, including collagen type I (COLI), alkaline phosphatase, bone sialoprotein, osteopontin, osteocalcin, cementum-derived protein (CP-23), dentin sialophosphoprotein (DSPP), and distal-less homeobox 3 (DLX3), as well as bone morphogenetic proteins (BMPs). In addition, they showed a high level of calcified nodule formation activity in vitro. CONCLUSIONS: We successfully established a cell line that may be useful for investigating the mechanisms of normal odontogenesis as well as characteristics of odontoma tumors.


Subject(s)
Cell Line, Tumor , Mesoderm/pathology , Odontoma/pathology , Adolescent , Adult , Aged , Alkaline Phosphatase/analysis , Biomarkers/analysis , Bone Morphogenetic Proteins/analysis , Calcification, Physiologic/physiology , Cell Culture Techniques , Cell Proliferation , Cell Shape , Child , Child, Preschool , Collagen Type I/analysis , Extracellular Matrix Proteins/analysis , Female , Fibroblasts/pathology , Homeodomain Proteins/analysis , Humans , Integrin-Binding Sialoprotein/analysis , Karyotype , Middle Aged , Odontoma/genetics , Osteocalcin/analysis , Osteopontin/analysis , Phosphoproteins/analysis , Proteins/analysis , Sialoglycoproteins/analysis , Telomerase/analysis , Transcription Factors/analysis , Young Adult
4.
Histol Histopathol ; 22(10): 1167-74, 2007 10.
Article in English | MEDLINE | ID: mdl-17616943

ABSTRACT

Periostin is a secreted protein that shares a structural homology to the axon guidance protein fasciclin I (FAS1) in insects and was originally named as osteoblast-specific factor-2 (Osf2). Periostin is particularly highly homologus to Betaig-h3, which promotes cell adhesion and spreading of fibroblasts. It has recently been reported that Periostin was frequently overexpressed in various types of human cancers. Although the detailed function of Periostin is still unclear, Periostin-integrin interaction through FAS1 domain is thought to be involved in tumor development. In addition, Periostin stimulates metastatic growth by promoting cancer cell survival, invasion and angiogenesis. Therefore, Periostin can be a useful marker to predict the behavior of cancer. This review summarizes the recent understanding of Periostin roles in tumor development and speculates on the usefulness of Periostin as a therapeutic and diagnostic target for cancer.


Subject(s)
Biomarkers, Tumor/metabolism , Cell Adhesion Molecules/metabolism , Neoplasms/metabolism , Animals , Disease Models, Animal , Female , Humans , Neoplasm Invasiveness/physiopathology , Neoplasm Metastasis/physiopathology , Neoplasms/diagnosis , Neovascularization, Pathologic/physiopathology , Recombinant Proteins/pharmacology
5.
J Bone Joint Surg Br ; 88(12): 1656-8, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17159183

ABSTRACT

Despite extensive experience with prosthetic replacement for the reconstruction of limbs following juxta-articular resection of tumours, there are few reports of prosthetic replacement of the distal radius. We present two cases of massive bone defects of the distal radius in which alumina ceramic prosthetic replacements were used. We evaluated the patients more than ten years after the procedure. Both patients had degenerative changes to the wrist. This, however, was not associated with pain or decreased function, and both had returned to their previous occupation after surgery. When a patient has a massive defect of the distal radius, reconstruction using a ceramic prosthesis is a reasonable alternative to using autograft. This method of treatment results in little pain, a moderate range of movement and satisfactory function.


Subject(s)
Bone Neoplasms/surgery , Giant Cell Tumor of Bone/surgery , Prostheses and Implants , Radius/surgery , Aluminum Oxide , Bone Neoplasms/diagnostic imaging , Ceramics , Follow-Up Studies , Giant Cell Tumor of Bone/diagnostic imaging , Humans , Male , Middle Aged , Radiography , Wrist Joint/surgery
6.
Br J Cancer ; 95(10): 1396-403, 2006 Nov 20.
Article in English | MEDLINE | ID: mdl-17060937

ABSTRACT

Oral squamous-cell carcinoma (OSCC) is one of the most common types of human cancer. Typically OSCC cells show persistent invasion that frequently leads to local recurrence and distant lymphatic metastasis. We previously identified Periostin as the gene demonstrating the highest fold change expression in the invasive clone by comparing the transcriptional profile of parent OSCC cell line and a highly invasive clone. Here, we demonstrated that Periostin overexpression enhanced invasiveness in oral cancer cell lines. To know the role of Periostin in invasion, angiogenesis and metastasis in OSCC cases, we first examined the expression of Periostin mRNA in 31 OSCC cases by RT-PCR and Periostin protein in 74 OSCC cases by immunohistochemistry. Then, we compared the Periostin expression with invasion pattern, metastasis and blood vessel density. Periostin mRNA and protein overexpression were frequently found in OSCC cases and Periostin expression was well correlated with the invasion pattern and metastasis. Moreover, blood vessel density of Periostin-positive cases was higher than those of Periostin-negative cases. Interestingly, recombinant Periostin enhanced capillary formation in vitro in a concentration-dependant manner. In summary, these findings suggest that Periostin may promote invasion and angiogenesis in OSCC, and that Periostin can be a strong marker for prediction of metastasis in oral cancer patients.


Subject(s)
Carcinoma, Squamous Cell/genetics , Cell Adhesion Molecules/genetics , Gene Expression Regulation, Neoplastic , Mouth Neoplasms/genetics , Neovascularization, Pathologic/genetics , Biomarkers, Tumor , Carcinoma, Squamous Cell/blood supply , Carcinoma, Squamous Cell/secondary , Cell Adhesion/physiology , Cell Adhesion Molecules/metabolism , Cells, Cultured , Disease Progression , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Humans , Lymphatic Metastasis , Mouth Neoplasms/blood supply , Mouth Neoplasms/pathology , Neoplasm Invasiveness/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Umbilical Veins/cytology , Umbilical Veins/metabolism
7.
Phys Rev Lett ; 95(10): 107005, 2005 Sep 02.
Article in English | MEDLINE | ID: mdl-16196956

ABSTRACT

While Josephson-junction-like structures intrinsic to the layered cuprate high temperature superconductors offer an attractive stage for exploiting possible applications to new quantum technologies, the low energy quasiparticle excitations characteristically present in these d-wave superconductors may easily destroy the coherence required. Here we demonstrate for the first time the feasibility of macroscopic quantum tunneling in the intrinsic Josephson junctions of a high temperature superconductor Bi(2)Sr(2)CaCu(2)O(8 + delta), and find it to be characterized by a high classic-to-quantum crossover temperature and a relatively weak quasiparticle dissipation.

8.
J Bone Joint Surg Br ; 87(7): 1006-11, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15972922

ABSTRACT

We examined osteochondral autografts, obtained at a mean of 19.5 months (3 to 48) following extracorporeal irradiation and re-implantation to replace bone defects after removal of tumours. The specimens were obtained from six patients (mean age 13.3 years (10 to 18)) and consisted of articular cartilage (five), subchondral bone (five), external callus (one) and tendon (one). The tumour cells in the grafts were eradicated by a single radiation dose of 60 Gy. In three cartilage specimens, viable chondrocytes were detected. The survival of chondrocytes was confirmed with S-100 protein staining. Three specimens from the subchondral region and a tendon displayed features of regeneration. Callus was seen at the junction between host and irradiated bone.


Subject(s)
Bone Neoplasms/surgery , Bone Transplantation/methods , Osteosarcoma/surgery , Adolescent , Bone Neoplasms/pathology , Bone Neoplasms/radiotherapy , Bone and Bones/pathology , Bone and Bones/radiation effects , Bone and Bones/surgery , Cartilage, Articular/pathology , Cartilage, Articular/surgery , Child , Chondrocytes/metabolism , Female , Humans , Immunohistochemistry/methods , Male , Necrosis , Osteosarcoma/pathology , Osteosarcoma/radiotherapy , S100 Proteins/analysis
9.
Anticancer Res ; 23(3C): 3045-9, 2003.
Article in English | MEDLINE | ID: mdl-12926159

ABSTRACT

Local recurrence-free survival rate for myxoid liposarcoma (MLS) is related to negative surgical margins. The goal of surgery in the treatment of MLS is to obtain tumor-free surgical margins. When a tumor is adjacent to critical structures, wider resection, which can result in amputation, would be selected for local control. While recognizing that marginal or intralesional resection is associated with high risk of recurrence, circumstances occur that lead surgeons to conduct conservative surgery. To determine whether marginal or intralesional resection combined with radiotherapy can achieve local control, 10 cases (12 tumors) were reviewed involving MLS treated with marginal (8 tumors) or intralesional resection (4 tumors) followed by postoperative radiotherapy (50-70 Gy, average 59.2 Gy). No recurrences of MLS were observed locally at the mean follow-up of 58.1 months. The development of severe radiation-related complications was not detected. This medium follow-up study suggested that this method can achieve a high rate of local control.


Subject(s)
Liposarcoma, Myxoid/radiotherapy , Liposarcoma, Myxoid/surgery , Adult , Aged , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
10.
J Orthop Res ; 20(3): 516-9, 2002 May.
Article in English | MEDLINE | ID: mdl-12038625

ABSTRACT

To study regulation of alternative splicing of type II collagen (COL2) pre-mRNA, we constructed a mouse COL2 "minigene" containing genomic sequences spanning exon 1 to exon 4 of COL2 downstream of a cytomegalovirus (CMV) promoter. This minigene was introduced into ATDC5 cells, which undergo chondrocytic differentiation when treated with insulin. Alternative splicing of the COL2 minigene was evaluated by comparing the expression of the two mRNAs transcribed from the minigene to the expression of alternatively spliced transcripts from the endogenous COL2 gene. This analysis suggested that regulation of alternative splicing of pre-mRNAs from the minigene and the endogenous COL2 gene are accomplished by similar mechanisms. We conclude that the cloned genomic fragment contains key sequences necessary for alternative splicing of COL2 pre-mRNA. This system provides a useful model to begin the process of identifying cis- and trans-acting factors that carry out alternative splicing of COL2 pre-mRNA during chondrocyte differentiation.


Subject(s)
Alternative Splicing , Collagen Type II/genetics , Animals , Cell Line , Cytomegalovirus/genetics , Mice , Peptide Fragments/genetics , Promoter Regions, Genetic/genetics , RNA Precursors/genetics , RNA, Messenger/metabolism
12.
J Orthop Sci ; 6(3): 269-75, 2001.
Article in English | MEDLINE | ID: mdl-11484122

ABSTRACT

Circulating tumor cells in the blood play a central role in the metastatic process. There have been no reports describing the relationship between lung metastasis and circulating osteosarcoma cells. We developed a system with a polymerase chain reaction assay based on an enzyme-linked immunosorbent assay (PCR-ELISA) to detect circulating osteosarcoma cells in a mouse metastatic model. Osf2/Cbfa1, hereafter called Osf2, a member of the runt family of transcription factors, was used as a target gene. One splicing variant of Osf2 mRNA was identified and its expression was restricted to the bones and osteosarcomas. The amount of the splicing variant of Osf2 mRNA was significantly higher in the blood of mice with metastasis than in the blood of the control group. The PCR-ELISA using Osf2 mRNA is a potential method to detect circulating osteosarcoma cells in peripheral blood.


Subject(s)
Bone Neoplasms/pathology , Disease Models, Animal , Neoplasm Proteins , Neoplastic Cells, Circulating , Osteosarcoma/secondary , Polymerase Chain Reaction/methods , Transcription Factors/metabolism , Alternative Splicing , Animals , Bone Neoplasms/blood , Bone Neoplasms/genetics , Core Binding Factor Alpha 1 Subunit , Enzyme-Linked Immunosorbent Assay , Gene Expression Profiling , Lung Neoplasms/secondary , Mice , Mice, Inbred C3H , Osteosarcoma/blood , Osteosarcoma/genetics , RNA Splicing , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/isolation & purification , Tumor Cells, Cultured
13.
Chem Pharm Bull (Tokyo) ; 49(7): 830-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11456087

ABSTRACT

A novel series of acyl-CoA: cholesterol O-acyltransferase (ACAT) inhibitors were synthesized from a lead compound, 1-(4-hydroxy-3-methoxyphenyl)-7-phenylhept-1-en-3-one (1, Yakuchinone B) through a modification of three regions (A, B, C) in the molecule. In this study, the compounds prepared were tested for in vitro inhibitory activity on microsomal ACAT from the liver of rats and for in vivo hypocholesterolemic activity in rats given a high cholesterol diet. N-(3,5-Dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine (45), which belongs to the amide compounds, has finally been discovered. Compound 45 inhibited rat hepatic ACAT in a more striking manner than CI-976, an amide compound ACAT inhibitor, and it exhibited a high level of hypocholesterolemic activity in vivo. Since 45 strongly inhibited both microsomal ACAT prepared from HepG2 (a cell line derived from human hepatocarcinoma) and Caco2 (a cell line derived from human colon adenocarcinoma), there is speculation that 45 might have the ability to inhibit ACAT in both the human intestine and liver independent of the difference in the distribution of ACAT isozymes. On the other hand, 45 did not induce adrenotoxicity in subacute toxicity studies in rats. These results suggest that it has promise for development as a new therapeutic agent for hypercholesterolemia and atherosclerosis.


Subject(s)
Anticholesteremic Agents/chemical synthesis , Anticholesteremic Agents/pharmacology , Cinnamates/chemical synthesis , Cinnamates/pharmacology , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Piperazines/chemical synthesis , Piperazines/pharmacology , Sterol O-Acyltransferase/antagonists & inhibitors , Animals , Caco-2 Cells , Cholesterol/blood , Cholesterol, Dietary/metabolism , Humans , Liver Neoplasms, Experimental/metabolism , Male , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship , Tumor Cells, Cultured
15.
Skeletal Radiol ; 30(2): 99-103, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11310207

ABSTRACT

Phosphaturic mesenchymal tumor is a rare neoplasm which causes osteomalacia or rickets. The tumor typically follows a benign clinical course. Even in the rare malignant cases, local recurrence and distant metastasis are uncommon. We report on an example of a malignant phosphaturic mesenchymal tumor which recurred several times over 16 years concurrently causing hypophosphatemia, bone pain, and osteomalacia. Following each surgery, symptoms and hypophosphatemia improved. The patient died of disease 17 years after the first surgery. Histologically, the initial tumor was composed of small spindle cells with clusters of giant cells, prominent blood vessels, poorly formed cartilaginous areas, and crystalline material. Cytological atypia was minimal. Following multiple recurrences, the tumor demonstrated areas of high-grade sarcoma exhibiting marked pleomorphism, numerous mitotic figures, and p53 overexpression. This case illustrates the potential lethality of incompletely removed phosphaturic mesenchymal tumors.


Subject(s)
Bone Neoplasms/diagnostic imaging , Osteomalacia/etiology , Phosphates/urine , Sarcoma/diagnostic imaging , Bone Neoplasms/complications , Bone Neoplasms/pathology , Bone and Bones/diagnostic imaging , Female , Fractures, Spontaneous/etiology , Humans , Hypophosphatemia/etiology , Lymphatic Metastasis , Middle Aged , Neoplasm Recurrence, Local , Osteomalacia/diagnostic imaging , Radiography , Sarcoma/complications , Sarcoma/pathology , Sarcoma/secondary
16.
Anticancer Res ; 21(1B): 649-55, 2001.
Article in English | MEDLINE | ID: mdl-11299821

ABSTRACT

BACKGROUND: Clear cell chondrosarcoma is a rare bone tumor, which is sometimes misdiagnosed as a different bone neoplasm. MATERIALS AND METHODS: The files of 6 patients with clear cell chondrosarcomas were reviewed. Histological slides, radiographic studies, and pre- and post-operative serum alkaline phosphatase (ALP) levels were evaluated. Molecular and histochemical analyses of ALP were documented in one case of clear cell chondrosarcoma. RESULTS: Pre-operative serum ALP levels were elevated in 3 patients, and were normal in another 3 patients. After removal of the tumors, the enzyme levels decreased in all patients and returned to normal in 3 patients, who had pre-operative high ALP levels. Enzyme histochemical and molecular analyses demonstrated that the tumor produced ALP. CONCLUSION: Clear cell chondrosarcoma produces ALP, which can be used as a tumor marker in diagnosis and follow-up.


Subject(s)
Alkaline Phosphatase/blood , Biomarkers, Tumor/blood , Bone Neoplasms/enzymology , Chondrosarcoma/enzymology , Neoplasm Proteins/blood , Adolescent , Adult , Bone Neoplasms/diagnosis , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/pathology , Bone Neoplasms/surgery , Child , Chondroblastoma/diagnosis , Chondroblastoma/enzymology , Chondrosarcoma/diagnosis , Chondrosarcoma/diagnostic imaging , Chondrosarcoma/pathology , Chondrosarcoma/surgery , Diagnosis, Differential , Diagnostic Errors , Female , Follow-Up Studies , Giant Cell Tumors/diagnosis , Giant Cell Tumors/enzymology , Humans , Male , Middle Aged , Osteolysis/diagnostic imaging , Osteolysis/enzymology , Osteolysis/etiology , Postoperative Period , Radiography
17.
J Bone Miner Metab ; 19(1): 20-8, 2001.
Article in English | MEDLINE | ID: mdl-11156469

ABSTRACT

In the present study, we investigated whether the in vivo bone-forming capacity of human bone marrow-derived stromal cells (HMSCs) could be enhanced by recombinant human bone morphogenetic protein-2 (rhBMP-2). The HMSCs obtained from seven donors (5-54 years of age) were passaged three to six times. Passaged HMSCs exhibited the osteoblastic phenotype in vitro, including: (a) an increase in alkaline phosphatase (ALP) activity in response to dexamethasone, ascorbic acid, and beta-glycerophosphate: and (b) mRNA expression for markers of osteoblastic lineage (ALP, osteopontin, osteocalcin, and parathyroid hormone-receptor) and BMP-2, -4, and -6 detected by reverse transcription-polymerase chain reaction. For the in vivo assay, transplants were subcutaneously implanted into nude mice as follows: group A (vehicle); group B (rhBMP-2); group C (HMSCs with vehicle); and group D (HMSCs with rhBMP-2). Transplants were obtained 2 and 4 weeks after implantation. Correlated radiographic findings, histological observations, and in situ hybridization using species-specific probes showed that the group B transplants contained bone tissue of mouse origin, which was observed at the periphery of the transplants. Four weeks after implantation, small amounts of HMSCs-derived bone tissue were detected at the periphery in two of seven transplants in group C. In contrast, five of seven group D transplants exhibited HMSCs-derived bone tissue, which was located at the center of the transplants and was surrounded by mouse bone tissue. Furthermore, HMSCs-derived chondrogenesis was detected in two of seven group D transplants. The results of the present study demonstrate that culture-expanded HMSCs preserve the osteoblastic phenotype, and the in vivo bone-forming capacity can be promoted by rhBMP-2.


Subject(s)
Bone Marrow Cells/physiology , Bone Morphogenetic Proteins/pharmacology , Osteoblasts/physiology , Osteogenesis , Transforming Growth Factor beta , Adolescent , Adult , Animals , Bone Marrow Transplantation , Bone Morphogenetic Protein 2 , Cells, Cultured , Child , Child, Preschool , Female , Humans , Male , Mice , Mice, Nude , Middle Aged , Recombinant Proteins/pharmacology , Stromal Cells/physiology , Stromal Cells/transplantation , Transplantation, Heterologous
18.
Int J Gynecol Pathol ; 19(4): 381-6, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11109170

ABSTRACT

We describe an epithelioid trophoblastic tumor (ETT) metastatic to the vagina in a 30-year-old Japanese woman. A polypoid tumor in the vaginal orifice was composed of nests of intermediate trophoblastic cells that showed a striking epithelioid appearance. In the hysterectomy specimen, a tumor infiltrated through the myometrium and showed histologic findings similar to those of the vaginal tumor. The tumor cells were positive for cytokeratin, inhibin-alpha, and melanoma cell adhesion molecule (Mel-CAM, CD146) but were only focally positive for human placental lactogen. Electron microscopic examination revealed bundles of well-developed, intermediate-type filaments surrounding the nuclei.


Subject(s)
Antigens, CD , Epithelioid Cells/pathology , Membrane Glycoproteins , Neural Cell Adhesion Molecules , Trophoblastic Neoplasms/secondary , Uterine Neoplasms , Vaginal Neoplasms/secondary , Adult , Antigens, Surface/analysis , Biopsy , CD146 Antigen , Cell Nucleus/pathology , Cytoplasm/pathology , Female , Humans , Immunohistochemistry , Inhibins/analysis , Intermediate Filaments/pathology , Keratins/analysis , Microscopy, Electron , Myometrium/pathology , Placental Lactogen/analysis , Pregnancy , Trophoblastic Neoplasms/chemistry , Trophoblastic Neoplasms/pathology , Vaginal Neoplasms/chemistry , Vaginal Neoplasms/pathology
19.
No Shinkei Geka ; 28(9): 789-94, 2000 Sep.
Article in Japanese | MEDLINE | ID: mdl-11025878

ABSTRACT

Six cases with recurrent or refractory primary central nervous system lymphoma were treated with a new chemotherapeutic regimen "DeVIC (dexamethasone, VP16, ifosfamide, carboplatin)". Five recurrent cases had a remission period for an average of 18 months after initial treatment, but relapse occurred. One refractory case had no response after initial treatment. Then these 6 cases were treated with 1-3 courses of DeVIC chemotherapy at intervals of 4 weeks. Two cases achieved complete remission, and 3 cases attained partial remission (response rate was 83%). One case showed no response after 1 course of DeVIC chemotherapy. However, in all cases re-relapse occurred 1-5 months after remission, and only 1 case is still alive. DeVIC chemotherapy produced a high response rate for recurrent central nervous system lymphoma, but re-relapse occurred after only a few months. The establishment of maintenance chemotherapy is required.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Neoplasms/drug therapy , Lymphoma/drug therapy , Adolescent , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carboplatin/administration & dosage , Combined Modality Therapy , Dexamethasone/administration & dosage , Etoposide/administration & dosage , Female , Humans , Ifosfamide/administration & dosage , Male , Middle Aged , Neoplasm Recurrence, Local , Remission Induction , Salvage Therapy , Treatment Outcome
20.
Phys Rev Lett ; 84(5): 875-8, 2000 Jan 31.
Article in English | MEDLINE | ID: mdl-11017394

ABSTRACT

We have observed quasinondestructive holographic storage with a continuous-wave laser at lambda = 532 nm in near-stoichiometric LiNbO3 doped with Tb and Fe. This crystal showed an exceptionally long grating decay time and also exhibited a fast color change upon exposure to ultraviolet (UV) light. It was demonstrated that the grating recorded from the UV-exposed, colored state can be continuously read out over 9 h at a reading intensity as high as 8 mW/cm(2). In addition, the written grating could be easily erased with UV illumination which returned the crystal back to the original colored state.

SELECTION OF CITATIONS
SEARCH DETAIL
...